510(k) Report

FDA applicant

Tianjin New Bay Bioresearch Co., Ltd.

Carlsbad, CA11 decisions2005–20132 recalls

FDA records 11 decisions for Tianjin New Bay Bioresearch Co., Ltd. (Carlsbad, CA) from 2005 to 2013: 11 510(k) clearances. Most are in product codes DJG (Enzyme Immunoassay, Opiates) and DKZ (Enzyme Immunoassay, Amphetamine). Its devices cite 12 predicates, 3 of them its own earlier devices. 2 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical toxicology panel, where it files most

How often FDA has decided Tianjin New Bay Bioresearch Co., Ltd.’s devices, and how often a recall has named them.

FDA decisions per year

2in 2013

2008: 22012: 12013: 2
2007high 2 (2008) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

2in 2011

2011: 2
2007high 2 (2011) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Tianjin New Bay Bioresearch Co., Ltd. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Tianjin New Bay Bioresearch Co., Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report